RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma

Jing Wang,1,* Ning Wang,1,* Wei-dong Zhao,2 Li-xian Zhao,2 Yong-guang Jing,3 Li-jie Yang,2 Jie He,2 Jun Li1 1Department of Surgery, School of Clinical Medicine, Dali University, Dali, Yunnan 671000, People’s Republic of China; 2The First Affiliated Hospital of Dali University, Dali, Yunnan...

Full description

Bibliographic Details
Main Authors: Wang J, Wang N, Zhao W, Zhao L, Jing Y, Yang L, He J, Li J
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/rna-seq-analysis-identified-xloc009190-as-potential-therapeutic-target-peer-reviewed-article-OTT
id doaj-1be6a8e34d9746bca7c051fea8339a9a
record_format Article
spelling doaj-1be6a8e34d9746bca7c051fea8339a9a2020-11-25T01:06:30ZengDove Medical PressOncoTargets and Therapy1178-69302019-12-01Volume 12112211122950544RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung AdenocarcinomaWang JWang NZhao WZhao LJing YYang LHe JLi JJing Wang,1,* Ning Wang,1,* Wei-dong Zhao,2 Li-xian Zhao,2 Yong-guang Jing,3 Li-jie Yang,2 Jie He,2 Jun Li1 1Department of Surgery, School of Clinical Medicine, Dali University, Dali, Yunnan 671000, People’s Republic of China; 2The First Affiliated Hospital of Dali University, Dali, Yunnan 671000, People’s Republic of China; 3Department of Human Anatomy, School of Basic Medical Sciences, Dali University, Dali, Yunnan 671000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun Li; Jing WangDepartment of Surgery, School of Clinical Medicine, Dali University, Xue-Ren Road, Xia Guang District, Dali, Yunnan 671000, People’s Republic of ChinaEmail Lijun6408@163.com; jingwang163@hotmail.comBackground: The abnormal regulation on the expression of lncRNAs had been linked to multiple kinds of cancers, including lung adenocarcinoma.Methods: In this study, we carried out RNA-Seq on the three tumors and their paired normal samples from Chinese patients with lung adenocarcinoma. All the transcripts were de novo assembled, among which all the possible lncRNAs were predicted by tools including PLEK, CNCI, CPC, Blastp, hmmscan, and so forth. Their expression levels, altogether with the annotated mRNAs, were quantified. The weighted correlation network analysis and analysis of differential expression were carried out to explain the biological function of these novel lncRNAs.Results: The weighted correlation network analysis showed that the lncRNAs, which were highly correlated with protein-coding genes, participated in various pathways, including PI3K kinase pathways. These lncRNAs were important regulators in biological processes. Next, the differentially expressed lncRNAs were identified, including four known lncRNAs and one novel lncRNA (XLOC_009190). The cis-regulation of this novel lncRNA might act on MGST1, which protected cells by conjugation and glutathione peroxidase functions. The trans-regulation of this lncRNA was investigated by its correlated mRNAs. The results showed that it possibly played a role in transmembrane receptors like G protein-coupled receptors and potassium channels.Conclusion: We proposed the potential biological function of XLOC_009190, but further experiments are needed to elucidate its roles and its potential to be the therapeutic target.Keywords: lung adenocarcinoma, RNA-Seq, lncRNAs, de novo assemblyhttps://www.dovepress.com/rna-seq-analysis-identified-xloc009190-as-potential-therapeutic-target-peer-reviewed-article-OTTlung adenocarcinomarna-seqlncrnasde novo assembly
collection DOAJ
language English
format Article
sources DOAJ
author Wang J
Wang N
Zhao W
Zhao L
Jing Y
Yang L
He J
Li J
spellingShingle Wang J
Wang N
Zhao W
Zhao L
Jing Y
Yang L
He J
Li J
RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma
OncoTargets and Therapy
lung adenocarcinoma
rna-seq
lncrnas
de novo assembly
author_facet Wang J
Wang N
Zhao W
Zhao L
Jing Y
Yang L
He J
Li J
author_sort Wang J
title RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma
title_short RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma
title_full RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma
title_fullStr RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma
title_full_unstemmed RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma
title_sort rna-seq analysis identified xloc_009190 as potential therapeutic target for lung adenocarcinoma
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2019-12-01
description Jing Wang,1,* Ning Wang,1,* Wei-dong Zhao,2 Li-xian Zhao,2 Yong-guang Jing,3 Li-jie Yang,2 Jie He,2 Jun Li1 1Department of Surgery, School of Clinical Medicine, Dali University, Dali, Yunnan 671000, People’s Republic of China; 2The First Affiliated Hospital of Dali University, Dali, Yunnan 671000, People’s Republic of China; 3Department of Human Anatomy, School of Basic Medical Sciences, Dali University, Dali, Yunnan 671000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun Li; Jing WangDepartment of Surgery, School of Clinical Medicine, Dali University, Xue-Ren Road, Xia Guang District, Dali, Yunnan 671000, People’s Republic of ChinaEmail Lijun6408@163.com; jingwang163@hotmail.comBackground: The abnormal regulation on the expression of lncRNAs had been linked to multiple kinds of cancers, including lung adenocarcinoma.Methods: In this study, we carried out RNA-Seq on the three tumors and their paired normal samples from Chinese patients with lung adenocarcinoma. All the transcripts were de novo assembled, among which all the possible lncRNAs were predicted by tools including PLEK, CNCI, CPC, Blastp, hmmscan, and so forth. Their expression levels, altogether with the annotated mRNAs, were quantified. The weighted correlation network analysis and analysis of differential expression were carried out to explain the biological function of these novel lncRNAs.Results: The weighted correlation network analysis showed that the lncRNAs, which were highly correlated with protein-coding genes, participated in various pathways, including PI3K kinase pathways. These lncRNAs were important regulators in biological processes. Next, the differentially expressed lncRNAs were identified, including four known lncRNAs and one novel lncRNA (XLOC_009190). The cis-regulation of this novel lncRNA might act on MGST1, which protected cells by conjugation and glutathione peroxidase functions. The trans-regulation of this lncRNA was investigated by its correlated mRNAs. The results showed that it possibly played a role in transmembrane receptors like G protein-coupled receptors and potassium channels.Conclusion: We proposed the potential biological function of XLOC_009190, but further experiments are needed to elucidate its roles and its potential to be the therapeutic target.Keywords: lung adenocarcinoma, RNA-Seq, lncRNAs, de novo assembly
topic lung adenocarcinoma
rna-seq
lncrnas
de novo assembly
url https://www.dovepress.com/rna-seq-analysis-identified-xloc009190-as-potential-therapeutic-target-peer-reviewed-article-OTT
work_keys_str_mv AT wangj rnaseqanalysisidentifiedxloc009190aspotentialtherapeutictargetforlungadenocarcinoma
AT wangn rnaseqanalysisidentifiedxloc009190aspotentialtherapeutictargetforlungadenocarcinoma
AT zhaow rnaseqanalysisidentifiedxloc009190aspotentialtherapeutictargetforlungadenocarcinoma
AT zhaol rnaseqanalysisidentifiedxloc009190aspotentialtherapeutictargetforlungadenocarcinoma
AT jingy rnaseqanalysisidentifiedxloc009190aspotentialtherapeutictargetforlungadenocarcinoma
AT yangl rnaseqanalysisidentifiedxloc009190aspotentialtherapeutictargetforlungadenocarcinoma
AT hej rnaseqanalysisidentifiedxloc009190aspotentialtherapeutictargetforlungadenocarcinoma
AT lij rnaseqanalysisidentifiedxloc009190aspotentialtherapeutictargetforlungadenocarcinoma
_version_ 1725189921563475968